A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma - Concepedia

Concepedia

Publication | Open Access

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma

DOI Full Paper Access

98

Citations

13

References

2015

Year

Anna K. Nowak, Alistair Cook, Alison M. McDonnell, Michael Millward, Jenette Creaney, Roslyn J. Francis, Arman Hasani, Amanda Segal, Arthur W. Musk, Berwin A. Turlach,

Annals of Oncology

Phase 1BMalignant Pleural MesotheliomaMedicineCd40-activating Antibody Cp-870,893ImmunologyPathologyPleural DiseaseOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1